• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lifestyle changes and 14-year change in high-density lipoprotein cholesterol in a cohort of male physicians.生活方式的改变与男性医师队列中高密度脂蛋白胆固醇 14 年的变化。
Am Heart J. 2011 Apr;161(4):712-8. doi: 10.1016/j.ahj.2010.12.015.
2
Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients.比较五种不同他汀类药物对冠心病患者高密度脂蛋白亚群谱的影响。
Atherosclerosis. 2002 Oct;164(2):361-9. doi: 10.1016/s0021-9150(02)00149-1.
3
Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study.比较匹伐他汀与阿托伐他汀在血脂异常和冠心病患者中升高高密度脂蛋白胆固醇和脂联素的作用:COMPACT-CAD 研究。
J Cardiol. 2013 Aug;62(2):87-94. doi: 10.1016/j.jjcc.2013.03.008. Epub 2013 May 11.
4
Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.他汀类药物治疗改变高危患者载脂蛋白B与低密度脂蛋白胆固醇及非高密度脂蛋白胆固醇目标之间的关系:MERCURY II(使用瑞舒伐他汀测量胆固醇有效降低)试验
J Am Coll Cardiol. 2008 Aug 19;52(8):626-32. doi: 10.1016/j.jacc.2008.04.052.
5
Effects of prescription omega-3-acid ethyl esters on non--high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatin.当与阿托伐他汀递增剂量合用时,处方型ω-3 酸乙酯对非高密度脂蛋白胆固醇的影响。
Mayo Clin Proc. 2010 Feb;85(2):122-8. doi: 10.4065/mcp.2009.0397.
6
Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.依泽替米贝单药治疗或与他汀类药物联合治疗对高密度脂蛋白胆固醇和低密度脂蛋白胆固醇的影响:一项随机对照试验。
JAMA. 2011 Nov 16;306(19):2099-109. doi: 10.1001/jama.2011.1649.
7
Dose-response effects of atorvastatin and simvastatin on high-density lipoprotein cholesterol in hypercholesterolaemic patients: a review of five comparative studies.阿托伐他汀和辛伐他汀对高胆固醇血症患者高密度脂蛋白胆固醇的剂量反应效应:五项比较研究的综述
Int J Cardiol. 2002 Jul;84(1):53-7. doi: 10.1016/s0167-5273(02)00118-3.
8
Atorvastatin administration after percutaneous coronary intervention in patients with coronary artery disease and normal lipid profiles: impact on plasma adiponectin level.冠心病且血脂水平正常的患者经皮冠状动脉介入治疗后服用阿托伐他汀:对血浆脂联素水平的影响
Clin Cardiol. 2008 Jun;31(6):253-8. doi: 10.1002/clc.20181.
9
Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.希腊阿托伐他汀与冠心病评估(GREACE)研究中低密度脂蛋白胆固醇(LDL-C)和非高密度脂蛋白胆固醇(non-HDL-C)水平与临床结局的关系
Curr Med Res Opin. 2004 Sep;20(9):1385-92. doi: 10.1185/030079904125004484.
10
Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.缓释烟酸与阿托伐他汀联合应用于高密度脂蛋白胆固醇水平较低患者的疗效与安全性
Indian Heart J. 2008 May-Jun;60(3):215-22.

引用本文的文献

1
Psychological well-being and restorative biological processes: HDL-C in older English adults.心理幸福感与恢复性生物过程:老年英国成年人的高密度脂蛋白胆固醇。
Soc Sci Med. 2018 Jul;209:59-66. doi: 10.1016/j.socscimed.2018.05.025. Epub 2018 May 14.
2
Treatment of dyslipidemia.血脂异常的治疗。
F1000Prime Rep. 2014 Mar 3;6:17. doi: 10.12703/P6-17. eCollection 2014.

本文引用的文献

1
No interaction between alcohol consumption and HDL-related genes on HDL cholesterol levels.饮酒与载脂蛋白相关基因对高密度脂蛋白胆固醇水平无交互作用。
Atherosclerosis. 2010 Aug;211(2):551-7. doi: 10.1016/j.atherosclerosis.2010.04.001. Epub 2010 Apr 13.
2
High-density lipoprotein subclasses are a potential intermediary between alcohol intake and reduced risk of cardiovascular disease: the Rancho Bernardo Study.高密度脂蛋白亚类是饮酒与降低心血管疾病风险之间的潜在中介:Rancho Bernardo 研究。
Br J Nutr. 2010 Oct;104(7):1034-42. doi: 10.1017/S0007114510001595. Epub 2010 Apr 29.
3
Coronary plaque regression and lifestyle modification in patients treated with pravastatin. - Assessment mainly by daily aerobic exercise and an increase in the serum level of high-density lipoprotein cholesterol -.普伐他汀治疗患者的冠状动脉斑块消退和生活方式改变。-主要通过每日有氧运动和增加血清高密度脂蛋白胆固醇水平来评估-。
Circ J. 2010 May;74(5):954-61. doi: 10.1253/circj.cj-09-0705. Epub 2010 Mar 17.
4
Physical activity, body mass index, and diabetes risk in men: a prospective study.体力活动、体重指数与男性糖尿病风险:一项前瞻性研究。
Am J Med. 2009 Dec;122(12):1115-21. doi: 10.1016/j.amjmed.2009.02.008.
5
High-density lipoprotein as a therapeutic target: a systematic review.作为治疗靶点的高密度脂蛋白:一项系统评价
JAMA. 2007 Aug 15;298(7):786-98. doi: 10.1001/jama.298.7.786.
6
Dyslipidemia and the risk of incident hypertension in men.男性血脂异常与新发高血压风险
Hypertension. 2006 Jan;47(1):45-50. doi: 10.1161/01.HYP.0000196306.42418.0e. Epub 2005 Dec 12.
7
Less than 50% of variation in HDL cholesterol between and within individuals, is explained by established predictors.
Atherosclerosis. 2006 Jan;184(1):178-87. doi: 10.1016/j.atherosclerosis.2005.03.032.
8
Predictors of 14-year changes in the total cholesterol to high-density lipoprotein cholesterol ratio in men.男性总胆固醇与高密度脂蛋白胆固醇比值14年变化的预测因素
Am Heart J. 2004 Jun;147(6):1033-8. doi: 10.1016/j.ahj.2003.11.018.
9
Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study.高密度脂蛋白胆固醇的生活方式决定因素:美国国立心肺血液研究所家族心脏研究
Am Heart J. 2004 Mar;147(3):529-35. doi: 10.1016/j.ahj.2003.10.033.
10
Comparison of baseline characteristics and mortality experience of participants and nonparticipants in a randomized clinical trial: the Physicians' Health Study.一项随机临床试验中参与者与非参与者的基线特征及死亡经历比较:医师健康研究。
Control Clin Trials. 2002 Dec;23(6):686-702. doi: 10.1016/s0197-2456(02)00235-0.

生活方式的改变与男性医师队列中高密度脂蛋白胆固醇 14 年的变化。

Lifestyle changes and 14-year change in high-density lipoprotein cholesterol in a cohort of male physicians.

机构信息

Massachusetts Veterans Epidemiology and Information Research Center, VA Boston Healthcare System, MA 02130, USA.

出版信息

Am Heart J. 2011 Apr;161(4):712-8. doi: 10.1016/j.ahj.2010.12.015.

DOI:10.1016/j.ahj.2010.12.015
PMID:21473970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3073688/
Abstract

BACKGROUND

Although cross-sectional studies have identified lifestyle factors associated with high-density lipoprotein cholesterol (HDL-C), no studies have examined the association between changes in lifestyle factors and long-term changes in HDL-C.

METHODS

We examined the association between changes in lifestyle factors and changes in HDL-C over a 14-year period in a cohort of 4,168 US male physicians, followed up between 1982 and 1997 and with HDL-C measured at both time points. Using linear regression, we examined the association between HDL-C change and categorized changes in alcohol consumption, physical activity, body mass index (BMI), and smoking, adjusting for age, baseline HDL-C, and other covariates.

RESULTS

Stable BMI of <25 kg/m(2) or BMI reduction from ≥25 to <25 kg/m(2) were associated with increases in HDL-C of 3.1 to 4.7 mg/dL over 14 years. Alcohol consumption of ≥1 drink daily or increase in alcohol consumption from <1 to ≥1 drink daily was associated with increases in HDL-C of 2.4 to 3.3 mg/dL over 14 years. Adopting a sedentary lifestyle was associated with decreases in 14-year decreases in HDL-C.

CONCLUSION

These findings suggest that reductions in BMI and increases in alcohol consumption are associated with 14-year increases in HDL-C, whereas decreases in physical activity are associated with 14-year decreases in HDL-C.

摘要

背景

尽管横断面研究已经确定了与高密度脂蛋白胆固醇(HDL-C)相关的生活方式因素,但尚无研究探讨生活方式因素的变化与 HDL-C 的长期变化之间的关系。

方法

我们在一个由 4168 名美国男性医生组成的队列中,检查了 14 年内生活方式因素的变化与 HDL-C 变化之间的关系,这些医生在 1982 年至 1997 年期间接受了随访,并在两个时间点测量了 HDL-C。我们使用线性回归,在校正年龄、基线 HDL-C 和其他协变量后,检查了 HDL-C 变化与饮酒、体力活动、体重指数(BMI)和吸烟分类变化之间的关联。

结果

稳定的 BMI<25 kg/m(2)或 BMI 从≥25 降至<25 kg/m(2)与 14 年内 HDL-C 增加 3.1 至 4.7 mg/dL 相关。每日饮酒≥1 杯或每日饮酒量从<1 增加到≥1 杯与 14 年内 HDL-C 增加 2.4 至 3.3 mg/dL 相关。采用久坐的生活方式与 14 年内 HDL-C 降低有关。

结论

这些发现表明,BMI 的降低和饮酒量的增加与 14 年内 HDL-C 的增加有关,而体力活动的减少与 14 年内 HDL-C 的降低有关。